Results 231 to 240 of about 69,782 (261)

Abstract LB-331: Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

, 2016
S. Seshagiri, E. Stawiski, L. Goldstein, S. Durinck, Z. Modrusan, Florian Gnad, Thong T. Nguyen, B. Jaiswal, A. Rienzo, W. Richards, R. Bueno   +10 more
semanticscholar   +1 more source

Malignant pleural mesothelioma

Current Problems in Cancer, 2004
Harvey I, Pass, Nicholas, Vogelzang, Steven, Hahn, Michele, Carbone   +3 more
openaire   +2 more sources

Malignant pleural mesothelioma

Critical Reviews in Oncology/Hematology, 1997
Hoogsteden, Henk, Langerak, Ton, Kwast, Theodorus, Versnel, Marjan, Gelder, Teun   +4 more
openaire   +3 more sources

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine, 2021
Patrick Forde, Valsamo Anagnostou, Suzanne E Dahlberg   +2 more
exaly  

Malignant pleural mesothelioma

Current Problems in Surgery, 1993
H I, Pass, H W, Pogrebniak
openaire   +2 more sources

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.

The Lancet Respiratory Medicine, 2019
M. Disselhorst, Josine Quispel-Janssen, F. Lalezari, K. Monkhorst, J. F. de Vries, V. van der Noort, E. Harms, S. Burgers, P. Baas   +8 more
semanticscholar   +1 more source

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

The Lancet Oncology, 2017
N. van Zandwijk, N. Pavlakis, S. Kao, A. Linton, M. Boyer, S. Clarke, Y. Huynh, A. Chrzanowska, M. Fulham, D. Bailey, W. Cooper, L. Kritharides, L. Ridley, Scott Pattison, J. MacDiarmid, H. Brahmbhatt, G. Reid   +16 more
semanticscholar   +1 more source

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Ca-A Cancer Journal for Clinicians, 2019
Michele Carbone, Prasad S Adusumilli, Paul Baas   +2 more
exaly  

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

The Lancet Oncology, 2017
E. Alley, Juanita Lopez, A. Santoro, A. Morosky, S. Saraf, B. Piperdi, E. V. van Brummelen   +6 more
semanticscholar   +1 more source